My name is Nnaemeka Emmanuel Nnadi. I am a medical Microbiologist My passion lies in deciphering how this changing climate fosters the emergence of novel and more formidable pathogens, posing a grave risk to human lives. Employing state-of-the-art technologies, I embark on a journey to uncover the intricate molecular evolution mechanisms driving the transformation of these pathogens, all while embracing the powerful one-health framework. My research delves deep into the complex web of interactions within microbial communities, with a sharp focus on their evolutionary trajectories. I wholeheartedly support the hypothesis that climate change is a catalyst for the birth of unprecedented pathogens, poised to threaten not only humans but also animals and plants alike
Secure funding, mentorship on how to run execute an impactful altruistic movement
If you have any questions about working in a resource-limited setting and wondering how to adapt the western idea to resource-limited settings.
TLDR:
I am a faculty member at Plateau State University, Nigeria, operating a charity laboratory focused on phage research for combating antimicrobial resistance. With a Ph.D. in Medical Microbiology, I offer a real-life perspective from resource-limited settings. Seeking a remote or hybrid part-time position in global health, particularly interested in infectious disease mitigation. Ready to start within the next few months.
Skills & Background:
Current faculty at Plateau State University, Nigeria
Ph.D. in Medical Microbiology
Expertise in working in resource-limited settings and rural communities
Location/Remote: Open to remote or hybrid positions
Availability & Type of Work: Seeking part-time position .Available to start in the next few months
Resume/CV/LinkedIn: https://www.linkedin.com/in/nnaemeka-emmanuel-nnadi-a39298b5/
Email: eennadi@gmail.com
How the centre for Phage biology and therapeutics would use more funding.
At Centre for Phage Biology and Therapeutics, our purpose is to maximise positive impact and make a real difference in world health. We are currently leading the effort to establish a large phage biobank in Nigeria, which is a vital step in pandemic preparedness. Phages have enormous promise, from vaccine manufacture to fighting drug-resistant bacteria, and our programme is set to make important contributions in these areas.
To further our effect, we need 20,000 USD to install a solar energy system that will provide sustainable and efficient power to our -80 Freezers. This not only secures the viability of our phage preservation efforts but also aligns with the ethos of effective altruism by optimizing resource allocation for maximum positive outcomes.
Your support will not only advance phage technology but also contribute to a safer, healthier world.
If you wish to know more, feel free to reach out to us via eennadi@plasu.edu.ng
What an extraordinary idea! I'm connecting with you from Jos, Nigeria. Presently, we're facing a shortage of electricity. For the last few days, we've only had electricity available from 12 am to 5:30 am daily. It's challenging for many to grasp the importance of a solar power system in such a situation. The energy costs here are unfavourable as well, negatively impacting research endeavours. I had previously hoped to acquire solar energy to fuel my laboratory, but financial constraints stood in the way. I applaud this initiative; it has the potential to breathe new life into our rural community.
Thanks Jeff for the reply. I had written on climate change and emerging pathogens earlier. Here is the link to a thought I had earlier
Hi Jeff, thanks for your response. I hold a PhD in Medical Microbiology and am a lecturer in the Department of Microbiology, at Plateau State University, Bokkos, Nigeria. My passion lies in deciphering how this changing climate fosters the emergence of novel and more formidable pathogens, posing a grave risk to human lives. I believe that climate change will make us more vulnerable to pathogens like fungi, however, I am realising that " natural pandemics" may not be an existential risk based on Toby Ord's opinion in "The Precipice". Do you think funders will be willing to fund research focused on looking at how climate change will lead to the evolution of pathogens leading to "natural" pandemics?
Thanks for this piece. This is particularly so because I hope to setup a biotech phage based company that will produce phage based solutions like phage thereby and phage vaccines. From my experience, when propeople talk about startups in LMICs the emphasis is usually on tech startups. The environment favors tech startups and not biotech startups.
I will give you my experience, we won an Emergent venture grant to setup a phage bank. This we have done and at the same time we have been working on two projects: Developing phage therapy for local strains of Psuedomonas and Salmonella typhi. We are pushing for enabling policies as well as how to move on to the next stage.
It will be interesting to read more about how to move to the next stage if you have a biotech startup experience.
So far, we have phages that kill 80% of our local strains. Planning to get on to pre-clinical trials. But thats the problem, which funder will agree to invest thousands of Dollars in an African biotech startup. If you have some thoughts on these issues I will be glad to read more or to interact.